-

MedsEngine Announces Integration with AthenaOne EHR at Volunteers in Medicine

DAYTON, Ohio--(BUSINESS WIRE)--MedsEngine LLC is excited to announce its clinical decision support application is now integrated with AthenaOne EHR at the Volunteers in Medicine (VIM) Clinic in Hilton Head, SC.

Dr. John Newman of VIM states, “partnering with MedsEngine allows our volunteer physicians, who come from a wide spectrum of medical backgrounds, to have greater confidence in their abilities to control chronic diseases in a primary care setting.”

“Integrating our application with AthenaOne EHR expands the availability of MedsEngine to improve chronic disease control,” said Douglas Romer, MD, CMO, MedsEngine. “Partnering with VIM underscores our combined dedication to providing enhanced outcomes for all patients.”

About MedsEngine

MedsEngine develops EHR-integrated clinical decision support applications that generate real-time, personalized, evidence-based medication recommendations for Hypertension, Cholesterol Management, Type 2 Diabetes, and Heart Failure resulting in improved clinical outcomes, higher HEDIS scores and Stars ratings, lower medical costs, standardized care recommendations for all providers, and greater patient understanding and satisfaction. For more information, visit http://www.medsengine.com/

About VIM

VIM serves the health and wellness of the medically underserved in the Hilton Head Island area. More than five hundred and fifty volunteers provide $13 million of free healthcare to over 28,000 uninsured patients annually. For more information, visit http://www.vimclinic.org

MedsEngine LLC


Release Versions

More News From MedsEngine LLC

MedsEngine Achieves High Blood Pressure Control In Less Than Two Office Visits

DAYTON, Ohio--(BUSINESS WIRE)--MedsEngine LLC, a provider of chronic disease management software, presented its findings on blood pressure control to the European Society of Hypertension in Milan, Italy, May 23-26, 2025. The findings showed that users of the MedsEngine Hypertension module were able to achieve high BP control rates, to a goal of <140/90, in less than two office visits. These results build on earlier presentations at the European Society of Cardiology Congress in 2023 and 2024...

MedsEngine Achieves SOC 2 Type II Certification: Reinforcing Our Commitment to Data Security

DAYTON, Ohio--(BUSINESS WIRE)--MedsEngine, a provider of chronic disease management software, is proud to announce that it has successfully attained SOC 2 Type II certification. This certification, awarded by the American Institute of Certified Public Accountants (AICPA), is a rigorous audit that evaluates a company's controls relevant to security, availability, processing integrity, confidentiality, and privacy. Dr. Doug Romer, CMO, stated, “this milestone underscores MedsEngine’s continued co...

MedsEngine Selected as Finalist in Payor Category of the Emerge Innovation Contest at HIMSS25

DAYTON, Ohio--(BUSINESS WIRE)--MedsEngine, a clinical decision support software designed to optimize treatment for hypertension, cholesterol, type 2 diabetes, and heart failure, is proud to announce they were selected as a finalist in the payor category of the Emerge Innovation Experience Contest at HIMSS25. Dr. Doug Romer, MedsEngine CMO, stated, “given the level of competition, having MedsEngine recognized among innovative solutions that are transforming healthcare delivery is truly an honor...
Back to Newsroom